Lung cancer

Lung cancer is a leading cause of cancer death in NZ. Two main types of lung cancer are non-small cell lung cancer and small cell lung cancer. Non-small cell lung cancer is much more common than small cell lung cancer. Most cases of lung cancer are caused by smoking. For most patients with lung cancer, current treatments do not cure the cancer. To see lung cancer registrations (total by year) on a map of NZ, region by region click here.

Lung Cancer Research Areas Involving NZ Researchers:

Lung Cancer and Behavioural Research

Associate Professor Andrea ‘t Mannetje, June Atkinson, Professor Tony Blakely, Professor Nick Wilson, Associate Professor Brian Cox, Dr Louise Marsh, Emeritus Professor Rob McGee, Associate Professor Tony Reeder, Dr Lindsay Robertson, 

Lung Cancer Biology

Molecular therapeutic targets: Dr Rebekah Bower 

Non-small cell lung cancer and treatment targets: Associate Professor John Ashton,

Lung Cancer Screening and Epidemiology

Associate Professor Brian Cox,

Lung Cancer Treatment, Including Pre-clinical Models and Clinical Trials

Professor Mark McKeage, Associate Professor Adam Patterson, Dr Maria Abbattista, Dr Jeff Smaill

Lung Cancer End-of-Life Care Research

Dr Kate Grundy, Dr Richard Egan

Lung Cancer Health Services and Outcomes Research

Professor Mark Elwood, June Atkinson, Professor Tony Blakely, Associate Professor Brian Cox,

Lung Cancer Patient Participation Research

Professor Mark Elwood, 

Standards of Service Provision for Lung Cancer Patients in New Zealand

This lung cancer tumour standard describes the level of service that a person with lung cancer in New Zealand should have access to. All of the recently developed provisional tumour standards include a number of standard statements that are generic across most cancers; they apply to all people with cancer and to all cancer types.